Skip to Main Content

Author Details

Martin K??bel
University of Calgary
2001
229
60
PMIDPaper TitleJournal TitlePublished Year
37406453TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.Int J Gynecol Pathol2024
37850576Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix.J Pathol2024
37925057Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation.Mod Pathol2024
37406453TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.Int J Gynecol Pathol2024
37850576Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix.J Pathol2024
37925057Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation.Mod Pathol2024
36368129Profiling the immune landscape in mucinous ovarian carcinoma.Gynecol Oncol2023
36368129Profiling the immune landscape in mucinous ovarian carcinoma.Gynecol Oncol2023
37820398Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.Gynecol Oncol2023
37580913Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype.Histopathology2023
37556934Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.Gynecol Oncol2023
37339172The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.Clin Cancer Res2023
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37182372Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085].Mod Pathol2023
36688720Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.J Natl Cancer Inst2023
36790339Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.Cancer Epidemiol Biomarkers Prev2023
36788084Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.Mod Pathol2023
37556934Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.Gynecol Oncol2023
37580913Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype.Histopathology2023
37820398Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.Gynecol Oncol2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37182372Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085].Mod Pathol2023
37339172The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.Clin Cancer Res2023
36790339Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.Cancer Epidemiol Biomarkers Prev2023
36788084Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.Mod Pathol2023
36688720Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.J Natl Cancer Inst2023
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
34596362Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features.J Pathol Clin Res2022
35715244Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes.Fertil Steril2022
35768582Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression.NPJ Precis Oncol2022
35394077Endometrial neuroendocrine carcinoma and undifferentiated carcinoma are distinct entities with overlap in neuroendocrine marker expression.Histopathology2022
36305537Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR).Int J Gynecol Pathol2022
36031730The proteome of clear cell ovarian carcinoma.J Pathol2022
36222710Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.Clin Cancer Res2022
35499168Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.Am J Surg Pathol2022
36065012Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images.Mod Pathol2022
37850594Corrigendum to "Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes" [Gynecologic Oncology, Volume 157, Issue 1, April 2020, Pages 36-45].Gynecol Oncol2022
33741764Dedifferentiation in Breast Metastasis of Endometrial Carcinoma: A Diagnostic Dilemma.Int J Gynecol Pathol2022
33770057Prognostic and Theranostic Biomarkers in Ovarian Clear Cell Carcinoma.Int J Gynecol Pathol2022
33720084Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies.Int J Gynecol Pathol2022
34799503Testing Algorithms for the Diagnosis of Malignant Glandular Tumors of the Uterine Cervix Histotyped per the International Endocervical Adenocarcinoma Criteria and Classification (IECC) System.Appl Immunohistochem Mol Morphol2022
35218556Cellular context determines DNA methylation profiles in SWI/SNF-deficient cancers of the gynecologic tract.J Pathol2022
34782936MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.Virchows Arch2022
34897700Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.J Pathol2022
34543435The utility of color normalization for AI-based diagnosis of hematoxylin and eosin-stained pathology images.J Pathol2022
35128856Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma.J Gynecol Oncol2022
34596362Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features.J Pathol Clin Res2022
34697060DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.Cancer Epidemiol Biomarkers Prev2022
35053578The Evolution of Ovarian Carcinoma Subclassification.Cancers (Basel)2022
  • 1 - 50 of 458

Recommended Authors

Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Career Start Year 2018
Number of shared co-authors 5
Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 11
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 7
Cathleen Matrai
Weill Cornell Medical Center
Career Start Year 2013
Number of shared co-authors 2
Ghassan Allo
Henry Ford Hospital
Career Start Year 2011
Number of shared co-authors 13
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 20
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 5
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 6
Yingmei Wang
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 1
Divya Gupta
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 3
Shin-Wha Lee
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 1
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 29
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 5
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 34
Karin Jirstr??m
Lund University
Career Start Year 2003
Number of shared co-authors 6
Saravut J Weroha
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 22
Aparna A Kamat
Houston Methodist Hospital
Career Start Year 2000
Number of shared co-authors 4
Susan C Modesitt
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 5
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 6
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 73
Kevin Holcomb
Weill Cornell Medical College
Career Start Year 1996
Number of shared co-authors 3
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 14
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 2
Yong-Man Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 2
Ernst Lengyel
University of Chicago
Career Start Year 1993
Number of shared co-authors 35
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 89
Holger Moch
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 15
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 5
Fr??d??ric Amant
Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 63
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 4

Collaborators

Cyril B Gilks
University of British Columbia
Co-authored papers 90
David G Huntsman
University of British Columbia
Co-authored papers 67
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 36
Steve E Kalloger
University of British Columbia
Co-authored papers 30
Michael S Anglesio
University of British Columbia
Co-authored papers 29
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 26
Anna DeFazio
Westmead Hospital
Co-authored papers 26
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 25
Aline Talhouk
The University of British Columbia
Co-authored papers 24
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 22
Stefan Kommoss
Eberhard Karls University Tubingen
Co-authored papers 22
Helen Steed
University of Alberta, Canada Cross Cancer Institute
Co-authored papers 21
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 21
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 20
Robert A Soslow
Co-authored papers 20
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 19
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 19
Samuel Leung
University of British Columbia
Co-authored papers 18
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 18
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 18
Mercedes Jimenez-Linan
University of Cambridge
Co-authored papers 17
Naveena Singh
Barts Health NHS Trust
Co-authored papers 17
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 16
M??ire A Duggan
University of Calgary, Cumming School of Medicine
Co-authored papers 16
Sian Fereday
Peter MacCallum Cancer Centre
Co-authored papers 16
Catherine J Kennedy
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers 16
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 15
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 15
Derek S Chiu
University of British Columbia, and Vancouver General Hospital
Co-authored papers 15
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 14
Release 1.2